AGENTS THAT SPECIFICALLY BLOCK CD28-MEDIATED SIGNALING AND USES THEREFOR

Details for Australian Patent Application No. 2002244051 (hide)

Owner GENETICS INSTITUTE, INC.

Inventors O'HARA, Richard, M., Jr.; NAGELIN, Ann, Marie

Pub. Number AU-A-2002244051

PCT Pub. Number WO2002/066059

Priority 60/269,756 16.02.01 US

Filing date 15 February 2002

Wipo publication date 4 September 2002

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 037/06 Drugs for immunological or allergic disorders

A61K 038/00 Medicinal preparations containing peptides

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-A-2002244051

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002244052-TERMINALLY-BRANCHED POLYMERIC LINKERS AND POLYMERIC CONJUGATES CONTAINING THE SAME

2002244050-MIXED ELECTROLYTE BATTERY